Welcome to Entry Card of Peptide


Details of TopicalPdb ID 1656

PRIMARY INFORMATION
ID1656
PMID12100989
Year2002
SequenceMALWMRLLPLLALLAL
WGPDPAAAFVNQHLCGSH
LVEALYLVCGERGFFYTPKTR
REAEDLQVGQVELGGGPG
AGSLQPLALEGSLQKRG
IVEQCCTSICSLYQLENYCN
NameInsulin
Length51
N-Terminal ModificationFree
C-Terminal ModificationFree
Linear/ CyclicLinear
ChiralityL
Chemical ModificationNone
Origin of PeptideSynthetic
Nature of Peptide/CargoNot mentioned
MechanismNot mentioned
Cargo Sequence/StructureNo cargo
Name of cargo
Not applicable
AssayFluorescence microscopy, glass vertical diffusion apparatus for electroporation.
Enhancer1,2-dimyristoyl-3-phosphatidylserine (DMPS)
Properties of enhancerIn the presence of DMPS there is greater than 20 fold enhancement of insulin transport.
ConcentrationSolution was made using 1ug/mL in Tris buffer and 25 ug total insulin was used for electoporation.
Incubation time10 minutes
Tissue permeability (value with units)The total insulin transport in the receiver compartment was around f13 Ag/cm2.
Tissue Sampleporcine epidermis
Ex vivo/In vivo/In vitroin vitro
SECONDARY INFORMATION
STRUCTURE
Predicted Structure
SMILESN[C@H](C(=O)N[C@H](C(=O)N[C@H](C
(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H]
(C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H]
(C(=O)N[C@H](C(=O)N[C@H](C(=O)
N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)
N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)
N1[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)
N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)
N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)
N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)
NCC(=O)N[C@H](C(=O)N[C@H](C(=O)
N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)
N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)
N[C@H](C(=O)N[C@H](C(=O)N[C@@H]
3C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)NCC
(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H]
(C(=O)N4[C@H](C(=O)N[C@H](C(=O)N[C@H](C
(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H]
(C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N
[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H]
(C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C
(=O)NCC(=O)NCC(=O)NCC(=O)N5[C@H](C(=O)NCC(=O)N[C@H]
(C(=O)NCC(=O)N[C@H](